Skip to main content Accessibility help
×
Home

Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome

  • Nizar Chahin (a1), Steven R. Zeldenrust (a2), Kimberly K. Amrami (a3), JaNean K. Engelstad (a1), P. James (a1) and B. Dyck (a1)...
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Two Causes of Demyelinating Neuropathy in One Patient: CMT1A and POEMS Syndrome
      Available formats
      ×

Abstract

Copyright

References

Hide All
1. Birouk, N, Gouider, R, Le Guern, E, Gugenheim, M, Tardieu, S, Maisonobe, T, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain. 1997;120(Pt 5):81323.
2. Dyck, PJ, Dyck, PJB, Chalk, CH. The 10 P’s: A mnemonic helpful in characterization and differential diagnosis of peripheral neuropathy. Neurology. 1992;42:148.
3. Dispenzieri, A, Kyle, RA, Lacy, MQ, Rajkumar, SV, Therneau, TM, Larson, DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101(7):2496506.
4. Dispenzieri, A. POEMS Syndrome. Hematology (Am Soc Hematol Educ Program). 2005:3607.
5. Dyck, PJ, Sherman, WR, Hallcher, LM, Service, FJ, O’Brien, PC, Grina, LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):5906.
6. Lupski, JR, de Oca-Luna, RM, Slaugenhaupt, S, Pentao, L, Guzzetta, V, Trask, BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66:21932.
7. Dyck, PJ, Swanson, CJ, Low, PA, Bartleson, JD, Lambert, EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc. 1982;57:23946.
8. Murakami, T, Oomori, H, Hara, A, Uyama, E, Mita, S, Uchino, M. Atypical phenotype of charcot-marie-tooth disease type 1A. Muscle Nerve. 1999;22(11):15936.
9. Malandrini, A, Villanova, M, Dotti, MT, Federico, A. Acute inflammatory neuropathy in Charcot-Marie-Tooth disease. Neurology. 1999;52(4):85961.
10. Gabriel, CM, Gregson, NA, Wood, NW, Hughes, RA. Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a). J Neurol Neurosurg Psychiatry. 2002;72(2):2305.
11. Vital, A, Vital, C, Lagueny, A, Ferrer, X, Ribiere-Bachelier, C, Latour, P, et al. Inflammatory demyelination in a patient with CMT1A. Muscle Nerve. 2003;28(3):3736.
12. Ginsberg, L, Malik, O, Kenton, AR, Sharp, D, Muddle, JR, Davis, MB, et al. Coexistent hereditary and inflammatory neuropathy. Brain. 2004;127(Pt 1):193202.
13. Carvalho, AA, Vital, A, Ferrer, X, Latour, P, Lagueny, A, Brechenmacher, C, et al. Charcot-Marie-Tooth disease type 1A: clinicopathological correlations in 24 patients. J Peripher Nerv Syst. 2005;10(1):8592.
14. Castleman, B, Towne, VW. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot. N Engl J Med. 1954;251(10):396400.
15. Castleman, B, Iverson, L, Menendez, VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956;9(4):82230.
16. Dispenzieri, A, Gertz, MA. Treatment of Castleman’s disease. Curr Treat Options Oncol. 2005;6(3):25566.
17. Keller, AR, Hochholzer, L, Castleman, B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29(3):67083.
18. Mallory, A, Spink, WW. Angiomatous lymphoid hamartoma in the retroperitoneum presenting with neurologic signs in the legs. Ann Intern Med. 1968;69(2):3058.
19. Donaghy, M, Hall, P, Gawler, J, Gregson, NA, Leibowitz, S, Jitpimolmard, S, et al. Peripheral neuropathy associated with Castleman’s disease. J Neurol Sci. 1989;89(2-3):25367.
20. Watanabe, O, Arimura, K, Kitajima, I, Osame, M, Maruyama, I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet. 1996;347:702.
21. Soubrier, M, Dubost, JJ, Serre, AF, Ristori, JM, Sauvezie, B, Cathebras, P, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum. 1997;40(4):7867.
22. Watanabe, O, Maruyama, I, Arimura, K, Kitajima, I, Arimura, H, Hanatani, M, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21(11):13907.
23. Dyck, PJ, Engelstad, J, Dispenzieri, A. Vascular endothelial growth factor and POEMS. Neurology. 2006;66(1):102.
24. Nishi, J, Arimura, K, Utsunomiya, A, Yonezawa, S, Kawakami, K, Maeno, N, et al. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman’s disease. Br J Haematol. 1999;104(3):4825.
25. Nishi, J, Maruyama, I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman’s disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma. 2000;38(3-4):38794.
26. Scarlato, M, Previtali, SC, Carpo, M, Pareyson, D, Briani, C, Del Bo, R, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005;128:191120.
27. Jaccard, A, Royer, B, Bordessoule, D, Brouet, JC, Fermand, JP. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood. 2002;99(8):30579.
28. Dispenzieri, A, Moreno-Aspitia, A, Suarez, GA, Lacy, MQ, Colon-Otero, G, Tefferi, A, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104(10):34007.
29. Dispenzieri, A, Gertz, MA. Treatment options for POEMS syndrome. Expert Opin Pharmacother. 2005;6(6):94553.
30. Kuwabara, S, Misawa, S, Kanai, K, Kikkawa, Y, Nishimura, M, Nakaseko, C, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology. 2006;66(1):1057.
31. Straume, O, Bergheim, J, Ernst, P. Bevacizumab therapy for POEMS syndrome. Blood. 2006;107(12):49723; author reply 3-4.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed